A chymotryptic-type serine protease is required for IL-2 production by Jurkat T cells. 1990

P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
INSERM U210, Faculte de Medecine, Nice, France.

Interleukin-2 (IL-2) production by activated Jurkat T cells was markedly delayed when these cells were treated with low concentrations of the chymotryptic-type protease inhibitor N-alpha-p-tosyl-L-phenylalanine chloromethylketone (TPCK). This increased lag time observed in the presence of TPCK directly correlates with the interaction of the inhibitor with a unique 42,000 molecular weight (MW) serine protease, which can be labelled with [3H]DFP, and was not due to an intracellular accumulation of a non-mature form of IL-2 nor to a non-specific inhibition of overall protein synthesis. The results presented in this report indicate that a 42,000 MW chymotryptic-like serine protease is required for IL-2 production by activated Jurkat T cells.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002918 Chymotrypsin A serine endopeptidase secreted by the pancreas as its zymogen, CHYMOTRYPSINOGEN and carried in the pancreatic juice to the duodenum where it is activated by TRYPSIN. It selectively cleaves aromatic amino acids on the carboxyl side. Alpha-Chymotrypsin Choay,Alphacutanée,Avazyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014108 Tosylphenylalanyl Chloromethyl Ketone An inhibitor of Serine Endopeptidases. Acts as alkylating agent and is known to interfere with the translation process. Chlorophenyltosylamidobutanone,TPCK,Tosylphenylalanyl Chloromethane,Chloromethane, Tosylphenylalanyl,Chloromethyl Ketone, Tosylphenylalanyl,Ketone, Tosylphenylalanyl Chloromethyl
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
February 1989, Journal of immunology (Baltimore, Md. : 1950),
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
January 1989, Cellular signalling,
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
August 1990, Journal of immunology (Baltimore, Md. : 1950),
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
January 2007, Cellular immunology,
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
August 1997, Journal of immunology (Baltimore, Md. : 1950),
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
June 1996, Journal of immunology (Baltimore, Md. : 1950),
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
June 2017, Journal of immunology (Baltimore, Md. : 1950),
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
January 2006, Journal of cellular physiology,
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
June 2004, Clinical immunology (Orlando, Fla.),
P Auberger, and S Sonthonnax, and J F Peyron, and B Mari, and M Fehlmann
July 2006, International immunopharmacology,
Copied contents to your clipboard!